Blood pressure recording over 24 hours is the best predictor of heart and vascular disease

High blood pressure is the most important treatable risk factor for diseases of the heart and the arterial system. Blood pressure recorded over 24 hours predicts these complications more accurately than blood pressure measured on a single occasion. That is the conclusion of an international study coordinated by Professors Jan A. Staessen and Zhen-Yu Zhang of KU Leuven in Belgium. […]

Read more

Metals influence C-peptide hormone related to insulin: New field of metalloendocrinology explores subtle effects of metals in body

Metals such as zinc, copper and chromium bind to and influence a peptide involved in insulin production, according to new work from chemists at the University of California, Davis. The research is part of a new field of “metalloendocrinology” that takes a detailed look at the role of metals in biological processes in the body. “We’re asking questions people didn’t […]

Read more

New approach uses magnetic beads to treat preeclampsia

Preliminary laboratory tests show that functionalized magnetic beads successfully reduced blood levels of a harmful molecule that is elevated during preeclampsia, according to new research in the American Heart Association’s journal Hypertension. Preeclampsia is a complication of pregnancy characterized by hypertension and kidney dysfunction that affects an estimated 6% — 8% of women in the U.S. who give birth each […]

Read more

Exposure to chemicals during pregnancy is not associated with an increase in blood pressure

Exposure to certain chemicals such as phthalates, parabens or Bisphenol A could be associated with a decrease in blood pressure during pregnancy. This is one of the main conclusions of a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by “la Caixa,” and published recently in the International Journal of Hygiene and Environmental Health. Hypertensive […]

Read more

Early clinical trial data show gene therapy reversing sickle cell anemia: Treatment uses reduced-intensity preconditioning to enhance its global transportability

After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults and showing early potential for transportability to resource-challenged parts of the world where SCA is most common. Preliminary data from a pilot Phase 1-2 clinical trial testing the gene-addition therapy were presented Dec. 3 […]

Read more

Genetic factor that can help or hurt risk for heart disease

Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide, responsible for more than 15 million deaths each year, including an estimated 610,000 people in the United States. Now, researchers may know one more reason why some people are more prone to develop the disease. In a paper published this month […]

Read more